Gabriel Brooks - Oct 18, 2023 Form 4 Insider Report for Solid Biosciences Inc. (SLDB)

Role
Chief Medical Officer
Signature
/s/ David Tyronne Howton as attorney-in-fact for Gabriel Brooks
Stock symbol
SLDB
Transactions as of
Oct 18, 2023
Transactions value $
$0
Form type
4
Date filed
10/20/2023, 04:23 PM
Next filing
Feb 16, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SLDB Employee Stock Option (Right to Buy) Award $0 +78K $0.00 78K Oct 18, 2023 Common Stock 78K $2.15 Direct F1
transaction SLDB Restricted Stock Units Award $0 +39K $0.00 39K Oct 18, 2023 Common Stock 39K Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was granted on October 18, 2023 ("Grant Date") and vests over four years, with 25% of the original number of shares vesting on the first anniversary of the Grant Date and 2.0833% of the original number of shares monthly thereafter until the fourth such anniversary.
F2 Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock (the "RSUs").
F3 The RSUs were granted on the Grant Date and vests over four years, with 25% of the original number of shares vesting on each anniversary of the Grant Date until the fourth such anniversary.